Skip to main content
Article thumbnail
Location of Repository

Effects of restless legs syndrome (RLS) on sleep

By Richard K Bogan


Restless legs syndrome (RLS) is a common neurological disorder characterized by an irresistible urge to move the legs, usually accompanied or caused by uncomfortable sensations in the legs. Symptoms are worse in the evening or at night than during the day and generally begin or worsen during periods of rest or inactivity. The chronic sleep disturbance often associated with RLS is likely due, at least in part, to the circadian nature of the symptoms. The relationship between disturbed sleep and reduced daytime functioning is well known and thus the accurate diagnosis and effective management of RLS is imperative

Topics: Review
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1999). A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.
  2. (1999). A randomized controlled study of pergolide in patients with restless legs syndrome.
  3. (2003). Acute double-blind, placebocontrolled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
  4. (2002). Acute placebocontrolled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci,
  5. (2004). An algorithm for the management of restless legs syndrome. Mayo Clin Proc,
  6. (1996). Augmentation of the restless legs syndrome with carbidopa/levodopa.
  7. (2003). Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure.
  8. (1997). Clinical, polysomnographic, and genetic characteristics of restless legs syndrome:a study of 133 patients diagnosed with new standard criteria. Mov Disord,
  9. (2004). Do periodic leg movements infl uence patients’ perception of sleep quality? Sleep Med,
  10. (1999). EEG and cardiac activation during periodic leg movements in sleep:support for a hierarchy of arousal responses.
  11. (2002). EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med,
  12. (2004). Epidemiology of restless legs in The Netherlands.
  13. (2000). Epidemiology of restless legs symptoms in adults.
  14. (2004). Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients:an open-label study. Ren Fail,
  15. (2004). Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population:the
  16. (2005). Institutes of Health.
  17. (1995). L-dopa therapy of uremic and idiopathic restless legs syndrome:a double-blind, crossover trial.
  18. (2001). Long-term effects of pergolide in the treatment of restless legs syndrome.
  19. (2004). Long-term safety and effi cacy of cabergoline for the treatment of idiopathic restless legs syndrome:results from an open-label 6-month clinical trial.
  20. (2004). Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
  21. (1997). Patterns of muscle activity in legs in sleep apnea patients before and during nCPAP therapy.
  22. (2004). Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
  23. (2001). Periodic leg movements and sleepiness in patients evaluated for sleep-disordered breathing.
  24. (2004). Periodic limb movement disorder and restless legs syndrome in dialysis patients. Nephrology
  25. (2001). Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord,
  26. (2002). Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis. Med Sci Monit,
  27. (1997). Prevalence, burden, and treatment of insomnia in primary care.
  28. (2005). Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med,
  29. (1998). Randomized, double-blind, placebocontrolled trial of pergolide in restless legs syndrome.
  30. (1999). Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial.
  31. (1986). Restless legs syndrome and periodic movements in sleep:physiopathology and treatment with L-dopa. Clin Neuropharmacol,
  32. (1999). Restless legs syndrome improved by pramipexole:a double-blind randomized trial.
  33. (2005). Restless legs syndrome prevalence and impact:REST general population study.
  34. (2005). Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant,
  35. (2003). Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med,
  36. (2001). Restless legs syndrome:a review of clinical and pathophysiologic features.
  37. (2004). Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
  38. (2006). Ropinirole in the treatment of patients with restless legs syndrome:a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc,
  39. (2004). Ropinirole in the treatment of restless legs syndrome:results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
  40. (2004). Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2:a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
  41. (1995). Sleep complaints are common in a dialysis unit.
  42. (2002). Subjective sleep quality and suggested immobilization test in restless leg syndrome and periodic limb movement disorder. Psychiatry Clin Neurosci,
  43. (2003). The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems.
  44. (2000). Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline—an open clinical trial.
  45. (1988). Treatment of restless legs syndrome and periodic movements during sleep with L-dopa:a double-blind, controlled study.
  46. (2002). Treatment of restless legs syndrome with gabapentin:a double-blind, cross-over study.
  47. (2002). Valvular heart disease in patients taking pergolide. Mayo Clin Proc,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.